Correct use and ease of use of a placebo dry powder inhaler in subjects with asthma and chronic obstructive pulmonary disease

por Feldman, Gregory J, Galkin, Dmitry V, Patel, Pinal, Collison, Kathryn A, Sharma, Raj
Publicado 2018

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis

por DiSantostefano, Rachael L, Li, Hao, Hinds, David, Galkin, Dmitry V, Rubin, David B
Publicado 2014

Clinical burden of illness among patients with severe eosinophilic COPD

por Müllerová, Hana, Meeraus, Wilhelmine H, Galkin, Dmitry V, Albers, Frank C, Landis, Sarah H
Publicado 2019

Predictors of pneumonia on routine chest radiographs in patients with COPD: a post hoc analysis of two 1-year randomized controlled trials

por Rubin, David B, Ahmad, Harris A, O’Neal, Michael, Bennett, Sophie, Lettis, Sally, Galkin, Dmitry V, Crim, Courtney
Publicado 2018

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

por Kerwin, Edward M, Kalberg, Chris J, Galkin, Dmitry V, Zhu, Chang-Qing, Church, Alison, Riley, John H, Fahy, William A
Publicado 2017

Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation

por Chuchalin, Alexander G, Khaltaev, Nikolai, Antonov, Nikolay S, Galkin, Dmitry V, Manakov, Leonid G, Antonini, Paola, Murphy, Michael, Solodovnikov, Alexander G, Bousquet, Jean, Pereira, Marcelo HS, Demko, Irina V
Publicado 2014

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics

por Liu, Mark C., Chipps, Bradley, Munoz, Xavier, Devouassoux, Gilles, Bergna, Miguel, Smith, Steven G., Price, Robert G., Galkin, Dmitry V., Azmi, Jay, Mouneimne, Dalal, Albers, Frank C., Chapman, Kenneth R.
Publicado 2021